- Featured News /
Together with partners, Novartis is committed to reimagining the fight against Chagas disease and advocating for an integrated, end-to-end care approach.
- Featured News /
We’re collaborating with AWS to build an enterprise-wide data and analytics platform to transform the way medicines are manufactured and delivered.
- Featured News /
New cell and gene manufacture in Stein offers hope for patients around the globe.
- Featured News /
On Tuesday September 1, 2019 Novartis and Microsoft announced a multiyear alliance which will leverage data & Artificial Intelligence (AI) to transform how medicines are discovered, developed and commercialized. Novartis is also establishing an AI Innovation Lab to empower associates to use AI across our business.
- Featured News /
Health experts from around the world met November 29 to discuss ways to tackle an emerging crisis.
- Featured News /
Novartis reaffirms commitment to fighting malaria and recognizes the dedication of our people and partners.
- Featured News /
Fourteen weeks. That’s how many weeks all new Novartis parents will get as minimum paid parental leave, regardless of gender, rolling out from July 1, 2019.
- Featured News /
Blood diseases place a huge burden on individual patients, their families and on wider society. Yet advances in hematology treatment give so much cause for hope. It’s our responsibility to turn that hope into reality. Hear from five bold advocates who inspire us.
- Featured News /
Novartis and other industry leaders call for action to address antimicrobial resistance, one of the world’s most serious public health challenges
- Featured News /
Volunteerism and giving back to communities where we live and work are more than just tradition; they’re core values.
Pagination
- ‹ Previous page
- 1
- …
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- …
- 20
- › Next page